Seeing Is Believing
Currently out of the existing stock ratings of Martin Auster, 87 are a BUY (69.6%), 7 are a SELL (5.6%), 31 are a HOLD (24.8%).
Analyst Martin Auster works with a stock forecast success ratio of 55.72% fulfilled within 171.31 days on average. Previously, Martin Auster worked at CREDIT SUISSE.
Martin Auster’s has documented 262 price targets and ratings displayed on 26 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 18-Sep-2023.
Analyst best performing recommendations are on SLDB (SOLID BIOSCIENCES LLC).
The best stock recommendation documented was for SLDB (SOLID BIOSCIENCES LLC) at 5/14/2019. The price target of $90 was fulfilled within 1 day with a profit of $4.8 (5.06%) receiving and performance score of 50.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
205
$22.5 (12.33%)
2 years 10 months 24 days ago
3/5 (60%)
$35.09 (20.65%)
938
Hold
173
$-9.5 (-5.21%)
156
2 years 10 months 26 days ago
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
190
$7.5 (4.11%)
194
3 years 1 months 25 days ago
9/11 (81.82%)
$34.41 (22.12%)
350
Hold
166
$-16.5 (-9.04%)
175
3 years 1 months 25 days ago
23/23 (100%)
$10.41 (6.69%)
828
Buy
155
3 years 2 months 22 days ago
7/7 (100%)
$36.79 (31.12%)
395
What Year was the first public recommendation made by Martin Auster?